Hemostatic
biomaterials show great promise in wound control for
the treatment of uncontrolled bleeding associated with damaged tissues,
traumatic wounds, and surgical incisions. A surge of interest has
been directed at boosting hemostatic properties of bioactive materials via mechanisms triggering the coagulation cascade. A wide
variety of biocompatible and biodegradable materials has been applied
to the design of hemostatic platforms for rapid blood coagulation.
Recent trends in the design of hemostatic agents emphasize chemical
conjugation of charged moieties to biomacromolecules, physical incorporation
of blood-coagulating agents in biomaterials systems, and superabsorbing
materials in either dry (foams) or wet (hydrogel) states. In addition,
tough bioadhesives are emerging for efficient and physical sealing
of incisions. In this Review, we highlight the biomacromolecular design
approaches adopted to develop hemostatic bioactive materials. We discuss
the mechanistic pathways of hemostasis along with the current standard
experimental procedures for characterization of the hemostasis efficacy.
Finally, we discuss the potential for clinical translation of hemostatic
technologies, future trends, and research opportunities for the development
of next-generation surgical materials with hemostatic properties for
wound management.